Outlook Therapeutics, Inc. (OTLK) insider trading
Over the last 12 months, 7 insiders bought $7.91M and 0 insiders sold $0 of Outlook Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Aug 14, 2026: Jahr Robert Charles bought 151,515 shares ($0)
- Aug 14, 2026: Kenyon Lawrence A bought 101,010 shares ($0)
- Aug 12, 2026: Sukhtian Ghiath M. bought 2,525,252 shares ($2.50M)
- Jul 29, 2026: Sukhtian Faisal Ghiath bought 95,398 shares ($100K)
- Jun 2, 2026: Haddadin Yezan Munther bought 29,000 shares ($24.1K)
- May 28, 2026: Sukhtian Ghiath M. bought 8,539,709 shares ($5.04M)
- May 27, 2026: Sukhtian Faisal Ghiath bought 122,174 shares ($50.1K)
- May 26, 2026: Hilzinger Kurt J bought 400,000 shares ($176K)
- May 26, 2026: Thurman Randy H bought 5,000 shares ($2.15K)
- May 26, 2026: Haddadin Yezan Munther bought 34,000 shares ($15.0K)